Digital Health

Role of health technology may distract, not empower providers & patients. A reminder via NY Review of Books essay

A personal essay in the New York Review of Books by Dr. Arnold Relman on his recent serious accident reminds us that not only does fate play an important role in our lives, but the limits of our health care system.  I urge you to read it.  But in addition to the horrific experience he (and his family) had to undergo (and he's a lucky one). Dr.

CDD Tells FDA to work with FTC on digital pharma ads

10 May 2010 Dr. Margaret Hamburg, Commissioner Dr. Josh Sharfstein, Principal Deputy Commissioner Food and Drug Administration 10903 New Hampshire Ave Silver Spring, MD 20993-0002 Dr. Hamburg and Dr. Sharfstein: The Center for Digital Democracy wants to commend the FDA for conducting its recent inquiry into social media and the digital marketing of drugs. But we would like to discuss with you, at your earliest convenience, several concerns connected to this inquiry.

CDD Tells FDA to work with FTC on digital pharma ads

10 May 2010

 

Dr. Margaret Hamburg, Commissioner

Dr. Josh Sharfstein, Principal Deputy Commissioner

Food and Drug Administration

10903 New Hampshire Ave

Silver Spring, MD 20993-0002

Dr. Hamburg and Dr. Sharfstein:

The Center for Digital Democracy wants to commend the FDA for conducting its recent inquiry into social media and the digital marketing of drugs. But we would like to discuss with you, at your earliest convenience, several concerns connected to this inquiry.

Drug Marketing Moves to Digital: How Pharmaceutical Companies Pitch Consumers Online

For the past 25 years, pharmaceutical companies have been permitted to market their products directly to consumers. More recently, in the years following the Food and Drug Administration’s relaxation of direct-to-consumer (DTC) advertising guidelines in 1997, spending on such promotion grew more than six-fold, reaching $5 billion by 2008.

Drug Marketing Moves to Digital: How Pharmaceutical Companies Pitch Consumers Online

For the past 25 years, pharmaceutical companies have been permitted
to market their products directly to consumers. More recently, in the years following
the Food and Drug Administration’s relaxation of direct-to-consumer (DTC)
advertising guidelines in 1997, spending on such promotion grew more than six-fold,
reaching $5 billion by 2008.

In the traditional media of print and broadcast, those DTC ads come
with lots of fine print, including warnings of possible side effects that most
consumers. But now that ever-increasing

CDD Asks FDA to Investigate Digital Marketing of Drugs and Health Products

For Immediate Release
March 1, 2010 jeff@democraticmedia.org
Center for Digital Democracy www.democraticmedia.org

CDD Asks Food and Drug Administration to Investigate
Digital Marketing of Drugs and Health Products

Urges FDA to Develop Rules to Address Behavioral Targeting and to Protect Consumer Privacy

Online Drug Marketing FDA Filing

28 February 2010

Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane
Room 1061
Rockville, MD 20852

Re: Docket No. FDA-2009-N-0441

Written Comments: Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools

Syndicate content